Kognitive Störungen bei älteren Patienten mit Niereninsuffizienz

 

 Permissions and Reprints

Zusammenfassung

Die Prävalenz von kognitiven Störungen bei Patienten mit Niereninsuffizienz ist hoch. Ein Screening kann jedoch mittels einfacher und schnell durchzuführender Tests erfolgen. Für CKD-Patienten gibt es gerade während der Hämodialysesitzungen zunehmende Möglichkeiten, ein kognitives Training durchzuführen.

Abstract

The prevalence of cognitive disorders in CKD-patients is high. A screening of dementia is easy to perform. There are increasing possibilities of cognitive training in dialysis patients.

• Literatur

• 1 Sarnak MJ, Tighiouart H, Scott TM et al. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology 2013; 80: 471-480
  CrossrefPubMedGoogle Scholar
• 2 Murray AM, Knopman DS. Cognitive impairment in CKD: no longer an occult burden. Am J Kidney Dis 2010; 56: 615-618
  CrossrefPubMedGoogle Scholar
• 3 Bugnicourt JM, Godefroy O, Chillon JM et al. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol 2013; 24: 353-363
  CrossrefPubMedGoogle Scholar
• 4 Djukic M, Wedekind D, Franz A, Gremke M, Nau R. Frequency of dementia syndromes with a potentially treatable cause in geriatric in-patients: analysis of a 1-year interval. Eur Arch Psychiatry Clin Neurosci 2015; 265: 429-438
  Google Scholar
• 5 Yaffe K, Ackerson L, Kurella TM et al. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc 2010; 58: 338-345
  CrossrefPubMedGoogle Scholar
• 6 Sedaghat S, Vernooij MW, Loehrer E et al. Kidney Function and Cerebral Blood Flow: The Rotterdam Study. J Am Soc Nephrol 2015; pii: ASN.2014111118
  PubMedGoogle Scholar
• 7 Tiffin-Richards FE, Costa AS, Holschbach B et al. The Montreal Cognitive Assessment (MoCA) – a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS One 2014; 9: e106700
  CrossrefPubMedGoogle Scholar
• 8 Deuschl G, Maier W. S3-Leitlinie “Demenzen”. Langversion – 1. Revision, August 2015. Im Internet: https://www.dgppn.de/fileadmin/user_upload/_medien/download/pdf/kurzversion-leitlinien/REV_S3-leiltlinie-demenzen.pdf (Letzter Zugriff: 17.2.2016)
  PubMedGoogle Scholar
• 9 Heiwe S, Jacobson SH. Exercise training in adults with CKD: a systematic review and meta-analysis. Am J Kidney Dis 2014; 64: 383-393
  CrossrefPubMedGoogle Scholar
• 10 Howard R, McShane R, Lindesay J et al. Donepezil and memantine for moderate-to-severe Alzheimer’s disease. N Engl J Med 2012; 366: 893-903
  CrossrefPubMedGoogle Scholar
• 11 Haefeli WE. Dosing – Hilfsmittel zur Arzneimittel-Anwendung & -Sicherheit. Dosierung bei Niereninsuffizienz. www.dosing.de (Letzter Zugriff: 17.2.2016)
  PubMedGoogle Scholar
• 12 Ying I, Levitt Z, Jassal SV. Should an elderly patient with stage V CKD and dementia be started on dialysis?. Clin J Am Soc Nephrol 2014; 9: 971-977
  CrossrefPubMedGoogle Scholar
• 13 Hoffmann U, Sieber C. Nierenersatztherapie im Alter – bei wem, wann, wie, wie lange?. Dtsch Med Wochenschr 2014; 139: 1568-1571
  Article in Thieme ConnectPubMedGoogle Scholar
• 14 Kurella TM, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009; 361: 1539-1547
  CrossrefPubMedGoogle Scholar
• 15 Douglas C, Murtagh FE, Chambers EJ, Howse M, Ellershaw J. Symptom management for the adult patient dying with advanced chronic kidney disease: a review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group. Palliat Med 2009; 23: 103-110
  CrossrefPubMedGoogle Scholar